Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...

Replimune (REPL) stock rebounds even as FDA rejection of its RP1 skin cancer drug lead to multiple analyst downgrades on Wall Street. Read more here.

BofA analyst Tim Anderson raised the firm’s price target on Amgen (AMGN) to $261 from $252 and keeps an Underperform rating on the shares. For Q2, ...

Morse Asset Management Inc has significantly increased its stake in Regeneron Pharmaceuticals, boosting its share count by a ...

Shares of Regeneron Pharmaceuticals Inc. REGN rallied 2.82% to $560.93 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06 ...

Lockheed Martin's Q2 sales hit $18.2 billion, fueled by missiles and F-35s. But there was also a $1.8 billion loss from ...